Hangzhou JUST Biotherapeutics Co., Ltd. is Hiring

1.     Company Profile

Established in January 2016, Hangzhou JUST Biotherapeutics Co., Ltd. is the commercial manufacturing partner of Just Biotherapeutics (JUST) that is invested by Bill & Melinda Gates Foundation, Merck Co., Lilly Asia Ventures and ARCH Venture Partners. It is founded by the senior veterans of Amgen, a world leading biopharmaceutical company.

JUST leverages the most innovative and proprietary platform, and combines intensified process development of antibody with highly integrated production flow, modularized factory design, as well as disposable technology to ensure flexible and efficient biologics manufacture. We specialize in developing anti-tumor and anti-infectious biosimilars, bio-betters and innovative drugs that are in line with international standards. Our mission is to design and apply innovative technologies to dramatically expand global access to biotherapeutics for all.

JUST Biotherapeutics is committed to bringing these world class technologies and products into China. In Hangzhou, we kicked off the construction of global center for R&D and Manufacturing in 2016, and plan to start GMP production in 2018. With our unique Sino-US cooperative business model and strong overseas market partners, JUST Biotherapeutics will provide biotherapeutics drugs that not only meet international quality standards, but also are affordable to patients in China and around the world.

Contact:

Please send your resume to: hr@justbiochina.com